Our results show that high-Myc expressing tumors are susceptible to DON-induced apoptosis and suggest that combining inhibitors to glutamine metabolism with antagonists to Bcl-2 family members could be a successful treatment strategy for these pediatric cancers. Here, MYC is linked to cancer.